{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T03:14:11Z","timestamp":1767237251893,"version":"3.46.0"},"reference-count":14,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,26]]},"DOI":"10.1515\/pp-2018-0101","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T10:58:35Z","timestamp":1522839515000},"source":"Crossref","is-referenced-by-count":13,"title":["The concept of \u201cObstruction-Free Survival\u201d as an outcome measure in advanced colorectal cancer management"],"prefix":"10.1515","volume":"3","author":[{"given":"Brendan J.","family":"Moran","sequence":"first","affiliation":[{"name":"Peritoneal Malignancy Institute Basingstoke , Basingstoke , United Kingdom of Great Britain and Northern Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexios","family":"Tzivanakis","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital , Basingstoke , United Kingdom of Great Britain and Northern Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2018,3,30]]},"reference":[{"key":"2025120909183248900_j_pp-2018-0101_ref_001_w2aab3b7b2b1b6b1ab1b2b1Aa","doi-asserted-by":"crossref","unstructured":"Moran B, Baratti D, Yan TD, Kusamura S, Deraco M. Consensus statement on the loco\u2010regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol 2008;15:9.","DOI":"10.1002\/jso.21054"},{"key":"2025120909183248900_j_pp-2018-0101_ref_002_w2aab3b7b2b1b6b1ab1b2b2Aa","unstructured":"https:\/\/www.nice.org.uk\/guidance\/ipg331."},{"key":"2025120909183248900_j_pp-2018-0101_ref_003_w2aab3b7b2b1b6b1ab1b2b3Aa","unstructured":"Moran BJ, Cecil TD. Treatment of surgically resectable colorectal peritoneal metastases. Br J Surg 2014;101:5\u20137.2425436410.1002\/bjs.9281"},{"key":"2025120909183248900_j_pp-2018-0101_ref_004_w2aab3b7b2b1b6b1ab1b2b4Aa","unstructured":"Garc\u00eda-Fadrique A, Mehta A, Mohamed F, Dayal S, Cecil T, Moran BJ. Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: a review. J Gastrointest Oncol 2017;8:915.2918469710.21037\/jgo.2017.08.01"},{"key":"2025120909183248900_j_pp-2018-0101_ref_005_w2aab3b7b2b1b6b1ab1b2b5Aa","unstructured":"Chua TC, Martin S, Saxena A, Liauw W, Yan TD, Zhao J, et al. Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy program. Ann Surg 2010;251:323\u20139.10.1097\/SLA.0b013e3181c9b53c"},{"key":"2025120909183248900_j_pp-2018-0101_ref_006_w2aab3b7b2b1b6b1ab1b2b6Aa","unstructured":"Ansari N, Chandrakumaran K, Dayal S, Mohamed F, Cecil TD, Moran BJ. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours. Eur J Surg Oncol 2016;42:1035\u201341.2713207210.1016\/j.ejso.2016.03.017"},{"key":"2025120909183248900_j_pp-2018-0101_ref_007_w2aab3b7b2b1b6b1ab1b2b7Aa","unstructured":"Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2008;27:681\u20135.19103728"},{"key":"2025120909183248900_j_pp-2018-0101_ref_008_w2aab3b7b2b1b6b1ab1b2b8Aa","unstructured":"Feng YF, Yu JG, Shi JL, Huang JH, Sun YL, Zhao YE. A meta-analysis of primary external dacryocystorhinostomy with and without mitomycin C. Ophthalmic Epidemiol 2012;19:364\u201370.2317120510.3109\/09286586.2012.733792"},{"key":"2025120909183248900_j_pp-2018-0101_ref_009_w2aab3b7b2b1b6b1ab1b2b9Aa","unstructured":"Cabourne E, Clarke JC, Schlottmann PG, Evans JR. Mitomycin C vs 5\u2010Fluorouracil for wound healing in glaucoma surgery. The Cochrane Library. 2015:1."},{"key":"2025120909183248900_j_pp-2018-0101_ref_010_w2aab3b7b2b1b6b1ab1b2c10Aa","doi-asserted-by":"crossref","unstructured":"Urkan M, \u00d6zerhan \u0130H, \u00dcnl\u00fc A, Can MF, \u00d6zt\u00fcrk E, G\u00fcnal A, et al. Prevention of intraabdominal adhesions: an experimental study using mitomycin-C and 4\u2006% icodextrin. Balkan Medical J 2017;34:5.","DOI":"10.4274\/balkanmedj.2015.1359"},{"key":"2025120909183248900_j_pp-2018-0101_ref_011_w2aab3b7b2b1b6b1ab1b2c11Aa","unstructured":"Ozerhan IH, Urkan M, Meral UM, Unlu A, Ers\u00f6z N, Demirag F, et al. Comparison of the effects of Mitomycin-C and sodium hyaluronate\/carboxymethylcellulose [NH\/CMC](Seprafilm) on abdominal adhesions. Springer Plus 2016;5:846.10.1186\/s40064-016-2359-2"},{"key":"2025120909183248900_j_pp-2018-0101_ref_012_w2aab3b7b2b1b6b1ab1b2c12Aa","unstructured":"Sugarbaker PH, Gianola FJ, Speyer JC, Wesley R, Barofsky I, Meyers CE. Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery 1985;98:414\u201322.3898450"},{"key":"2025120909183248900_j_pp-2018-0101_ref_013_w2aab3b7b2b1b6b1ab1b2c13Aa","unstructured":"Girshally R, Demtr\u00f6der C, Albayrak N, Zieren J, Tempfer C, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 2016;14:253.10.1186\/s12957-016-1008-027678344"},{"key":"2025120909183248900_j_pp-2018-0101_ref_014_w2aab3b7b2b1b6b1ab1b2c14Aa","doi-asserted-by":"crossref","unstructured":"Odendahl K, Solass W, Demtr\u00f6der C, Giger-Pabst U, Zieren J, Tempfer C, et al. Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC). Eur J Surg Oncol 2015;41:1379\u201385.2613828310.1016\/j.ejso.2015.06.001","DOI":"10.1016\/j.ejso.2015.06.001"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/pp\/3\/1\/article-20180101.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2018-0101\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2018-0101\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T09:21:14Z","timestamp":1765272074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2018-0101\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,1]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,3,30]]},"published-print":{"date-parts":[[2018,3,26]]}},"alternative-id":["10.1515\/pp-2018-0101"],"URL":"https:\/\/doi.org\/10.1515\/pp-2018-0101","relation":{},"ISSN":["2364-768X","2364-7671"],"issn-type":[{"type":"electronic","value":"2364-768X"},{"type":"print","value":"2364-7671"}],"subject":[],"published":{"date-parts":[[2018,3,1]]},"article-number":"20180101"}}